National Association of Testing Authorities, Australia
Scope of Accreditation
Australian Genome Research Facility
Site
AGRF – Melbourne MT
Accreditation No.
14332
Site No.
24278
Date of Accreditation
02 Jul 2018
Address
Level 13 , Victorian Comprehensive Cancer Centre , 305 Grattan Street
Melbourne, VIC 3000
Australia
Contact
Availability
Services available to external clients
Supervision
Not Applicable
Scope of Accreditation
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Service | Product | Determinant |
---|---|---|
Molecular genetics - DNA extraction | Blood; Buccal swabs; Formalin-fixed paraffin-embedded (FFPE) tissues; Saliva | DNA storage for future analyses; Purified PCR product; Viable DNA; Viable DNA for sequencing and other molecular assays |
Molecular genetics - DNA fragment size analysis | Fluorescent-labelled DNA sequencing reaction product | DNA fragment size determination |
Molecular genetics - DNA sequencing | Extracted DNA | Sequenced DNA by Sanger sequencing; Sequenced DNA utilising massively parallel sequencing technologies |
Molecular genetics - Heterozygous loci determinations | Extracted DNA | Nucleic acid analysis for specific variants |
Molecular genetics - Investigation of constitutional genetic variants - Carrier testing - Targeted genes | Blood; Extracted DNA; Mouth swabs | Fragile X syndrome (FRAXA); Nucleic acid analysis for specific variants; Spinal muscular atrophy |
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Whole exome sequencing studies for inherited (germline) DNA/RNA changes | Extracted DNA | Nucleic acid analysis for unknown variants |
Molecular genetics - Predictive genetic testing - Targeted genes | Buccal swabs; Extracted DNA; Saliva | Polygenic risk score (PRS) - Glaucoma |
Molecular genetics - RNA extraction | Formalin-fixed paraffin-embedded (FFPE) tissues | Purified PCR product; RNA storage for future analyses; Viable RNA; Viable RNA for molecular diagnostics; Viable RNA for sequencing |
Molecular genetics - Screening for an unknown mutation - Microarray analysis for inherited (germline) DNA/RNA changes | Extracted DNA | Nucleic acid analysis for unknown variants |
Molecular genetics - Screening for an unknown mutation - Targeted panels for non-inherited (somatic) DNA/RNA changes | Formalin-fixed paraffin-embedded (FFPE) tissues | RNA; Solid tumours |
Molecular genetics - Screening for an unknown mutation - Whole genome sequencing studies for inherited (germline) DNA/RNA changes | Extracted DNA | Nucleic acid analysis for unknown variants |
Molecular genetics/Cytogenetics - Bioinformatic analysis | DNA sequences; FASTQ files | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
14332
Site No.
24278
Print date
21 Nov 2024